MAG (Myelin-associated glycoprotein) is a type I transmembrane glycoprotein expressed by Schwann cells and oligodendrocytes, that has been implicated in the control of axonal growth in many neuronal populations including cerebellar granule neurons (CGNs). However, it is unclear whether MAG has other functions in central nervous system, in particular, in cerebellar development and patterning. We find that MAG expression in the cerebellum is compartmentalised resulting in increased MAG protein levels in the cerebellar white matter. MAG induces apoptosis in developing CGNs through p75NTR signalling. Deletion of p75NTR in vivo reduced the number of apoptotic neurons in cerebellar white matter during development leading to reduction in the size of white matter in the adulthood. Furthermore, we show that MAG impairs CGNs neurite outgrowth as consequence of MAG-induced apoptosis in CGNs. Mechanistically, we find that MAG/NgR1-induced cell death is dependent of p75NTR-mediated activation of JNK/cell death signalling pathway. Together, these findings identify the mechanisms by which MAG induces CGNs apoptotic activity, a crucial event that facilitates cerebellar layer refinement during development.
The cerebellum is one of the most architecturally elaborated regions in the nervous system (NS). The fundamental determinant of cerebellar morphology is the correct allocation of different cell types in each specific territory. However, the molecular mechanisms governing the establishment and maintenance of the boundaries defining the different cerebellar regions are not fully understood. Cerebellar granule neurons (CGNs) start developing postnatally, forming a transitional cerebellar external granule layer (EGL), where the cells proliferate and then migrate to the internal granule layer (IGL)1. Although, molecules promoting CGNs migration have been identified1, it remains unclear what factors prevent CGNs migration beyond the granule layer (GL).
Myelin-associated glycoprotein (MAG) is a type I transmembrane protein expressed by myelinating glia, Schwann cells and oligodendrocytes of the peripheral and central nervous system (PNS and CNS, respectively), being preferentially enriched on the periaxonal layer of myelinated axons2,3,4,5,6. MAG functions as a bimodal factor, promoting axonal growth in embryonic neurons while inhibiting axonal growth in adult neurons, specifically in dorsal root ganglion neurons (DRG), retinal ganglion cells (RCG), spinal cord motor neurons, hippocampal neurons (HCN) superior cervical ganglion (SCG) neurons and CGNs5,6,7,8,9,10. MAG signals through several receptors including Nogo receptors 1 and 2 (NgR1 and NgR2)11,12,13. In the NS, MAG’s inhibitory effect on axonal growth requires the p75 neurotrophin receptor (p75NTR) as a co-receptor with NgR1, but not NgR28,13,14,15,16.
p75NTR activates several signalling pathways including NFkB17,18,19,20, JNK/cell death21,22 and RhoGDI/RhoA/ROCK9,14,23,24,25 depending on the availability of different ligands and adaptor proteins20. Through the p75NTR/NgR1 receptor complex, MAG activates the RhoGDI/RhoA/ROCK signalling pathway by recruiting the adaptor protein RhoGDI to the p75NTR death domain, leading to growth cone collapse and axonal growth retardation9,14,23,24,25. Recently, one study showed that MAG/p75NTR signalling impairs migration of Schwan cells and induces cell death in vitro and blockage of this pathway increases migration and survival of Schwan cells in demyelinating adult CNS26. We therefore ask whether MAG may prevent CGNs migration beyond the GL and into the white matter (WM).
In this study we examined the effect of MAG in developing CGNs and its contribution to defining the cerebellar GL/WM boundary. We found that MAG facilitates CGNs apoptotic activity both in vitro and in vivo, contributing to cerebellar layer refinement and to the maintenance of properly defined and functioning layers in adult cerebellum.
MAG, its receptor (NgR1) and co-receptor (p75NTR) are expressed in the cerebellum
To establish the role of MAG in developing CGNs, we started the investigation by studying the expression pattern of MAG, NgR1 and p75NTR in CGNs in vivo and in vitro. MAG was expressed in P2, P4, P7, P10, P14 and P60 cerebellar (Fig. 1a–c). MAG immunoreactivity was detected diffusely along the whole P2 and P4 cerebellar, while in P7, P10, P14 and P60 cerebella, it was compartmentalised specifically in the WM (Fig. 1a–c). NgR1 was expressed only in P2, P4, P7 and P10 cerebella (Fig. 1a, b). An intense expression of p75NTR was detected in P2, P4, P7 and P10 cerebella followed by negligible levels in P14 and P60 (Fig. 1a). The highest expression of p75NTR was localised in the Purkinje cell layer (Fig. 1a) in agreement with a previous report27. To establish the expression pattern of these molecules in CGNs, we imaged the IGL of folium III from P2 to P14. MAG was expressed in both the IGL and WM at P2 and P4, while was present exclusively in WM at older ages (Fig. 1b, c). Myelinating glia cells that express MAG also express p75NTR 28,29,30. In the folium III IGL, MAG and p75NTR expression overlapped at P2 and P4, while at P7 and P10 the expression of p75NTR was markedly decreased and was undetectable from P14 onwards (Fig. 1b). NgR1 was expressed at P2, P4, P7 and P10, with the highest expression detected at P7, and it was absent from P14 onwards (Fig. 1b). At P2 and P4 the NgR1 positive cells do not express p75NTR (Fig. 1b, c), suggesting that any effects exerted by MAG in CGNs must be in a paracrine manner. All IGL neurons expresses p75NTR at P7 and P10 and a subset of those also co-express NgR1 (Fig. 1b, c).
To verify whether MAG and its receptors are expressed specifically in CGNs, we evaluated their expression in cultured CGNs by immunocytochemistry. As previously observed in vivo, CGNs in culture express NgR1 and p75NTR but not MAG (Fig. 2a, b).
Quantitative PCR (qPCR) analysis revealed NgR1 (Fig. 2c) and p75NTR transcripts (Fig. 2e) in cultured CGNs. Since MAG binds to NgR211,16, we evaluated its expression and found its transcripts in cultured CGNs (Fig. 2d). MAG binds other receptors such as paired immunoglobulin-like receptor B (PirB)31, Integrin beta 1 (ITGB1)32 and gangliosides (GD1a and GT1b)8. qPCR analysis revealed PirB and ITGB1 transcripts in cultured CGNs (Suppl. Fig. 1a-b). We did not examine the presence of gangliosides in those samples because it is not possible to evaluate their expression levels by qPCR, however, since P9 CGNs lysate contains GD1a and GT1b8, we expect their presence in P7 CGNs. Upon binding to MAG, these receptors have been suggested to interact with p75NTR 7,8,10,31,32,33 making it conceivable that could mediate MAG’s effects in CGNs.
MAG induces apoptosis through p75NTR in developing CGNs contributing to WM layer refinement
MAG inhibits neurite growth in different cell types by inducing growth cone collapse through p75NTR 5,6,10,27. However, whether MAG also facilitates cell death in CGNs, that is crucial in shaping the cerebellar architecture, has not been explored. Since p75NTR is a death receptor, we asked whether MAG induces cell death in developing CGNs and if such effect is mediated by p75NTR. We first examined the effect of MAG on wild type (p75NTR+/+) CGNs in vitro using both propidium iodide (PI) incorporation and cleaved caspase 3 immunoreactivity in the same cultures treated with either Fc fragment (control) or MAG-fusion protein (MAG-Fc) for 24 h. PI stains both necrotic and apoptotic cells, while cleaved caspase 3 will only label apoptotic cells. We observed an increase in PI incorporation in MAG-Fc treated neurons compared to control (Supplementary Fig 2a,b). Similar to PI results, there was an increase in cleaved caspase 3 positive neurons in cultures treated with MAG-Fc compared to control (Supplementary Fig 2a,c). Although, the fold increase in cell death between PI and cleaved caspase 3 positive cells was similar, the number of PI positive cells in control cultures was higher suggesting that some of the cells died independently of MAG-Fc treatment. We therefore, used cleaved caspase 3 staining for subsequent experiments. Next, we investigated the involvement of p75NTR in CGN death. As expected from previous observations (Supplementary Fig 2a,b), p75NTR+/+ CGNs treated with MAG-Fc for 24 h had increased cleaved caspase 3 positive neurons compared to control (Fig. 3a, b). Interestingly, p75NTR knockout (p75NTR−/−) neurons did not respond to MAG-Fc (Fig. 3a, b). MAG exerts its effect by binding to receptors such as NgR1, PirB, β1-integrin and gangliosides, which in turn recruit p75NTR to transduce MAG signal7,15,33,34. To determine which of these receptors play a role in MAG-induced cell death of CGNs, we treated p75NTR+/+ CGNs with either MAG-Fc, competitive antagonist of NgR1 (NEP1-40) or MAG-fc plus NEP1-40 for 24 h. As expected, MAG-Fc treatment increased the percentage of cleaved caspase 3 positive CGNs (Fig. 3c). NEP1-40 alone had no effect on CGN death (Fig. 3c). However NEP1-40 blocked MAG-Fc induced cell death in p75NTR+/+ CGNs (Fig. 3c) suggesting that MAG-mediated cell death in developing CGNs requires NgR1 and p75NTR.
To assess whether the results obtained in cultured CGNs are relevant for CGN survival in vivo, we counted the number of cleaved caspase 3 positive cells in the WM of P7 and P10 p75NTR+/+ and p75NTR−/− cerebellar. The number of cleaved caspase 3 positive cells was markedly reduced in p75NTR−/− cerebellar WM compared to the p75NTR+/+ littermates (Fig. 3d–f), in agreement with a role for MAG/p75NTR signalling in CGN death and WM layer refinement in the developing cerebellum. To confirm that the cleaved caspase 3 cells in the WM were indeed neurons, we stained P7 and P10 p75NTR+/+ cerebellar sections with antibodies against cleaved caspase 3 together with markers for neurons (NeuN), oligodendrocytes (MAG), astrocytes (GFAP) and microglia (Iba1). Cleaved caspase 3 colocalized with NeuN only (Fig. 3g), confirming that these cells are indeed neurons. We then asked whether this CGN death contributes to maintenance of the GL/WM boundary in the adult cerebellum. Consecutive midsagittal adult (6–9-months-old) cerebellar sections stained with hematoxylin and eosin revealed a significant reduction in the WM thickness of folia III, VIII and X in p75NTR−/− cerebella (Fig. 4a–c) and a trend towards a decrease in the remaining folia (Fig. 4a–c). Conversely, the GL thickness was significantly increased in folia I/II, VII and X and a trend towards an increase was observed in folia III, IV/V (Fig. 4a, b, d). These data suggest that CGN death mediated by MAG/p75NTR signalling contributes to the maintenance of cerebellar GL/WM boundary.
MAG-induced apoptotic activity in developing CGNs hinders CGN neurite outgrowth
Next, we investigated the relationship between the effects of MAG on CGN death and its reported ability to inhibit axonal growth. We treated CGNs with Fc fragment or MAG-Fc for 24 h, measured the length of the longest neurite and assessed the proportion of neurite-bearing CGNs. The neurite length of p75NTR+/+ and p75NTR−/− CGNs was similar and MAG-Fc did not alter the length (Fig. 5a, b). However, the percentage of neurite-bearing p75NTR+/+ CGNs was markedly decreased upon MAG-Fc compared to Fc fragment treatment, while percentage of p75NTR−/− CGNs bearing neurite remain the same after both treatments (Fig. 5a, c). These data suggest that MAG is involved in the initiation of axonal growth of the CGNs but plays no role in the neurite elongation. To ascertain whether this neurite inhibition effect was a consequence of MAG-induced cell death, p75NTR+/+ CGNs were cultured and treated with Fc fragment or MAG-Fc for 24 h. As expected, the percentage of cleaved caspase 3 positive CGNs was increased in MAG-Fc treated neurons (Fig. 5d) compared to control. Surprisingly, the cleaved caspase 3 positive cells had either a short or no neurite, while cleaved caspase 3 negative neurons had neurites with similar length as control cells (Fig. 5d). These data suggest that the MAG-induced neurite inhibition effect in CGNs is a result of MAG-induced apoptosis. To confirm this, we cultured and treated p75NTR+/+ CGNs with the cell-permeant caspase 3-inhibitor, Z-DEVD-FMK 30 min prior to and during MAG-Fc treatment. As expected, p75NTR+/+ CGNs treated only with MAG-Fc showed no difference in neurite length (Fig. 5e, f) but a marked decrease in the percentage of neurons bearing neurites compared to control neurons (Fig. 5e, g). Interestingly, treatment with Z-DEVD-FMK abrogated MAG effect on neurite formation (Fig. 5e, g), emphasising that the reduction in CGNs bearing-neurites induced by MAG is a consequence of increased apoptotic activity in CGNs.
MAG-induced apoptosis requires p75NTR-mediated activation of RhoGDI/cell death pathway
p75NTR couples to different signalling pathways including NFkB17,18,19,20,27, JNK/ cell death21,22 and RhoGDI9,14,23,24,25 depending on the cellular context20. To determine which p75NTR signalling pathway is activated by MAG in developing CGNs, we devised a rescue experiment in p75NTR−/− neurons transfected with cDNA constructs of wild type p75NTR (p75WT) or p75NTR mutants that are selectively deficient in distinct signalling pathways20,35. The p75NFkB construct contains the triple mutation D355A/H359A/E363A in the p75NTR death domain that prevents the recruitment of RIP2 thereby hindering p75NTR-mediated activation of NFkB20,27,35,36. The p75RhoGDI/cell death construct carries the double mutation D410A/S413A in the p75NTR death domain that uncouples p75NTR from RhoGDI and JNK/cell death pathways simultaneously, thereby hindering activation of RhoA and cell death pathways35,36. p75NTR−/− neurons transfected with pcDNA had the same level of apoptosis upon treatment with MAG-Fc or to Fc fragment (Fig. 6a, b). Transfection of p75WT or p75NFkB mutants into p75NTR−/− CGNs restored the ability of MAG to induce cell death (Fig. 6a, b), indicating that MAG-mediated CGN death is dependent on p75NTR but independent of the NFkB pathway. On the other hand, p75RhoGDI/cell death construct blocked MAG-induced cell death in these neurons (Fig. 6a, b), suggesting that either the RhoGDI or JNK/cell death pathways, or both, are required for MAG-induced cell death in developing CGNs.
To further characterise if these two signalling pathways also play a role in inhibition of neurite formation, we transfected p75NTR−/− CGNs with pcDNA, p75WT or p75RhoGDI/cell death constructs. Twenty-four hours after transfection, the cells were treated with Fc fragment or MAG-Fc for 24 h. Neurons transfected with p75WT had a marked increase in neurite length and branching compared to pcDNA transfected neurons upon Fc fragment treatment (Fig. 6c–e), indicating a net positive effect of p75NTR overexpression on neurite outgrowth in these neurons. MAG had no effect on neurite length or branching of p75NTR−/− CGNs transfected with pcDNA but reduced neurite outgrowth in p75WT transfected neurons, although the decrease was not greater than in pcDNA transfected cells (Fig. 6c–e), indicating that the reduction was a result of MAG-induced cell death. Furthermore, CGNs transfected with p75RhoGDI/cell death construct did not respond to MAG-Fc treatment (Fig. 6c–e).
MAG-mediated CGN death requires activation of the JNK pathway
The inhibition of axonal growth mediated by MAG could be due to activation of RhoGDI/RhoA/ROCK signalling through p75NTR 9,24, but our data on genetic inactivation of p75NTR-mediated RhoGDI/cell death pathways also suggest that the cell death pathway could be involved. Unfortunately, currently there are no p75NTR signalling mutants that can selectively separate those two activities.
To determine which signalling pathway is mediating MAG-induced cell death in CGNs, p75NTR+/+ neurons were treated with Y-27632, a selective Rho Kinase (ROCK) inhibitor, or JNK-IN-8, a JNK-pathway inhibitor, 30 min prior and during Fc fragment or MAG-Fc treatments. As previously shown, CGNs treated with MAG-Fc alone had increased cleaved caspase 3 immunoreactivity compared to Fc fragment (Fig. 7a–b). Y-27632 did not abrogate MAG-induced apoptosis in CGNs (Fig. 7a, b), while MAG-Fc failed to induce apoptosis in JNK-IN-8 treated neurons (Fig. 7a, b). These data suggest that MAG couples p75NTR to the JNK/cell death signalling pathway to facilitate apoptosis in CGNs.
To verify the activation of JNK signalling pathway, we evaluated phosphorylation of c-Jun on threonine 91 (Thr91) residue, known to be crucial for CGNs apoptosis27,37, in p75NTR+/+ CGNs treated with Fc fragment or MAG-Fc. MAG-Fc treatment increased Thr91 c-Jun phosphorylation by six-fold compared to untreated or Fc fragment treated cells (Fig. 7c, d). To further demonstrate the involvement of JNK signalling pathway in MAG-mediated CGNs apoptosis, we transfected p75NTR−/− CGNs with p75WT construct prior to JNK-IN-8 plus Fc fragment or JNK-IN-8 plus MAG-Fc treatment. Confirming our earlier observations, MAG-Fc induced apoptosis in p75NTR−/− neurons transfected with p75WT but not pcDNA (Fig. 7e, f), and this effect was blocked by JNK-IN-8 treatment. Collectively, these data indicate that MAG induces cell death in developing CGNs by facilitating p75NTR-mediated activation of the JNK/cell death signalling pathway.
MAG, a minor component of myelin in the CNS and PNS inhibits neurite outgrowth and axonal regeneration4,5,8,10. Although there is a burgeoning of literature on the role of MAG in developing NS, the effect of MAG has been predominately focused on neurite outgrowth and axonal regeneration7,8,10. We show that MAG, its receptor, NgR1, and co-receptor, p75NTR, are expressed in the developing cerebellum. We found that from P2 to P4, MAG expression was diffused, while from P7 onwards it was compartmentalised in the WM. Since MAG is reported to be expressed by myelin producing cells27,28,29,30, we suggest that the expression in developing cerebellum is restricted to oligodendrocytes. We propose that compartmentalisation of MAG is a way to ensure increased MAG protein levels specifically in the cerebellar WM.
NgR1 and p75NTR were expressed from P2 to P10, suggesting that the effect of MAG through NgR1/p75NTR is restricted to these ages. The proportion of CGNs in the IGL at P2 is low but increased markedly with age1, arguing that the NgR1 and p75NTR expression might not be on CGNs. Interestingly, the highest levels of colocalization between NgR1 and p75NTR in CGNs were found at P7, the prime point of cerebellar development with the highest levels of CGN apoptotic activity. The absence of MAG in CGNs suggests that it exerts its effect in a paracrine manner to induce apoptosis in the CGNs expressing both NgR1 and p75NTR. PirB and ITGB1are expressed by CGNs and therefore they could be also relevant for MAG-induced apoptosis. However, functional data using NgR antagonist proved that NgR1 is required. MAG exert its diverse biological effects through distinct and cell-specific mechanisms10,34,38,39. In addition to growth inhibition, MAG protects neurons from acute toxicity34, excitotoxicity40 and is required for axon regeneration39. These and our data highlight the beneficial effect of MAG signalling in the NS and emphasises the diversity of MAG signalling.
In agreement with the in vitro data, we observed increased apoptosis in p75NTR+/+ compared to p75NTR−/− neurons in the WM that resulted in distorted GL/WM boundary in adult cerebellum. The absence of MAG/NgR1/p75NTR signalling allows CGNs to migrate beyond the GL/WM boundary without consequences until they are stopped by other boundaries such as Purkinje cells axon bundle. We propose that, under physiological conditions, the migrating CGNs that fail to read the stop signal at the cerebellar GL/WM border will enter the WM compartment where they will be exposed to high concentration of MAG. Upon exposure, MAG induces CGNs cytoskeleton collapse and subsequently cell death by similar mechanisms as the ones described for growth cone collapse41. In our hands, high concentration (25 μm/ml) of MAG-induced CGN death, while lower concentration had no effect (data not shown). Since oligodendrocytes also express p75NTR 42, the in vivo effect of MAG on CGNs could be a result of a non-cell autonomous effect. However, our in vitro data where oligodendrocytes are absent, suggest that MAG exerts its effect directly on CGNs.
We propose that MAG is one of the factors involved in the maintenance of cerebellar GL/WM boundary. One report demonstrated that netrin 1 and its receptor UNC5H3 are involved in establishing the GL/WM border by constraining CGNs in the GL43. However, it remains unclear what happens to the CGNs that enter the WM compartment. Our study is the first to our knowledge to provide evidence that MAG, through NgR1/p75NTR, induces apoptosis of CGNs that fail to read migratory stop cues, thereby refining the WM layer.
Acute MAG/NgR1/p75NTR signalling is essential for growth cone collapse but not for neurite outgrowth inhibition41,42,43. In agreement with that, we show that MAG has no effect in axonal length and neurite elongation in CGNs, but affects initiation of neurite outgrowth. Many neurons failed to initiate neurite outgrowth upon MAG treatment and the majority of these neurons were also apoptotic. Treatment with cleaved caspase 3 inhibitors abrogated MAG effect on neurite formation, suggesting that this phenotype was a result of MAG-induced cell death.
In agreement with previous reports, MAG-induced cell death in p75NTR+/+ but not in p75NTR−/− CGNs, confirming that MAG’s apoptotic activity requires p75NTR 12,13,38. Interaction of MAG with NgR1/p75NTR receptor complex activates the RhoA/ROCK signalling pathway leading to axonal growth inhibition9,44, protection of neurons from acute toxicity and excitotoxicity34,40 and cell death45. One report suggested that MAG, through NgR1/NgR2/p75NTR, modulates motor neurons survival after injury in a RhoGDI/RhoA/ROCK signalling-dependent manner45. In our study, inhibition of RhoGDI/RhoA/ROCK signalling pathway did not abrogate MAG-induced apoptosis, suggesting that this pathway is not required. On the contrary, our data revealed that MAG-induced apoptosis in CGNs requires p75NTR-mediated activation of the JNK/cell death pathway. Both genetic and pharmacological inactivation of p75NTR/JNK/cell death pathway hindered MAG-mediated CGN death, while inactivation of RhoGDI/RhoA/ROCK pathway had no effect. Furthermore, MAG induced JNK activity leading to phosphorylation of c-Jun on Thr91. Our data constitutes the first evidence showing that MAG/NgR1/p75NTR complex engages the JNK signalling pathway.
Previously, we reported that p75NTR, through the RIP2/NFkB signalling pathway promotes CGN survival upon NGF binding27. Pharmacological and genetic manipulations of the RIP2/NFkB pathway leads to CGN death27. In the current study, we show that p75NTR can also induce cell death in a subset of CGNs, as a response to a different ligand (MAG) and direct activation of a different intracellular cascade (JNK/cell death pathway) increasing the versatility of this receptor. During cerebellar development most CGNs should survive and arrive to the IGL. However, in physiological conditions a percentage of these neurons should die to remove the excess of neurons and refine cell density in the IGL. Here, we show that the CGNs expressing both NgR1 and p75NTR that carry on migrating past the IGL into the WM layer die through MAG-induced activation of NgR1/p75NTR/JNK signalling. The fact that MAG at P7 is already specifically expressed in the cerebellar WM, suggests that this apoptotic mechanism is controlling the elimination of CGNs entering the WM. Since MAG is present in the WM in most areas of the CNS, in the future it will be of interest to investigate whether MAG contributes to WM layer refinement occurs beyond cerebellum.
In summary, we report that MAG induces apoptosis in CGNs by activating the NgR1/p75NTR/JNK/cell death signalling pathway, contributing to cerebellar WM layer refinement in developing cerebellum. Our discovery of MAG-mediated apoptosis in developing cerebellum increases our appreciation of the diversity and complexity of MAG signalling in the NS.
Materials and methods
Mice were housed in a 12-h light/dark cycle and fed a standard chow diet. The transgenic mouse line used was p75NTR knockout (p75NTR−/−) mice46. p75NTR−/− mice were maintained in a C57BL/6J background. Mice of both sexes were used for the experiments. All animal experiments were conducted in accordance with the Stockholm North Ethical Committee for Animal Research regulations and the National University of Singapore Institutional Animal Care and Use Committee.
Immunohistochemistry and immunocytochemistry
For immunohistochemistry, P2, P4, P7, P10, P14 or P60 animals were perfused first with PBS, followed by 4% paraformaldehyde. Harvested brains were post fixed in 4% paraformaldehyde for 16 h and cryoprotected in 30% sucrose before freezing. OCT-embedded brains were frozen at -80 °C overnight and serially sectioned at 10 or 20μm in the sagittal plane using a cryostat. Midline sections were mounted onto electrostatic charged slides (Leica Microsystems), blocked with 5% donkey serum (Fisher scientific) containing 0.3% Triton X-100 (Sigma) in PBS for 1 h at room temperature and then incubated for 16 h at 4 °C with primary antibodies. The sections were washed in PBS before incubated with the appropriate secondary antibodies and counterstained with DAPI (1:10000).
For immunocytochemistry, the cultures were fixed in 4% paraformaldehyde and 4% sucrose for 15 min and washed with PBS before blocking nonspecific binding and permeabilizing with blocking solution (5% donkey serum and 0.3% Triton X-100) in PBS for 1 h at room temperature. Neurons were incubated overnight with the primary antibodies in 1% blocking solution at 4 °C. After washing with PBS, the cultures were incubated with the appropriate secondary antibodies.
The primary antibodies used in this study were: polyclonal anti-p75NTR (Neuromics, GT15057, 1:200), monoclonal anti-MAG (Millipore, Mab1567, 1:200), polyclonal anti-Nogo receptor (NgR1, Alomone, ANT-008, 1:200), polyclonal anti-cleaved caspase 3 (Cell signal, 9761, 1:400), monoclonal anti-NeuN (Millipore, MAB377, 1:200), monoclonal anti-GFAP (Abcam, 1:500), polyclonal anti-Iba1 (Abcam, Ab5076, 1:200), monoclonal anti–β-III tubulin (R&D systems, MAB1195, 1:10000), polyclonal anti-MAP2 (Abcam, ab5392, 1:2000) and polyclonal anti-GFP (Abcam, ab13970, 1:500). Secondary antibodies were Alexa Fluor–conjugated anti-immunoglobulin from Life Technologies, Invitrogen, used at 1:1000 (donkey anti-rabbit IgG Alexa Fluor 555, A31572, donkey anti-goat IgG Alexa Fluor 488, A11055, donkey anti-mouse IgG Alexa Fluor 488, A21202, donkey anti-mouse IgG Alexa Fluor 555, A31570, donkey anti-mouse IgG Alexa Fluor 647, A31571, donkey anti-goat IgG Alexa Fluor 555, A21432 and donkey anti-chicken IgG Alexa Fluor 647, Jackson, 703-496-155). Images were obtained using a Zeiss Axioplan confocal microscope.
RNA preparation and quantitative PCR
The levels of NgR1, NgR2 and p75NTR mRNAs were quantified by quantitative PCR (qPCR) in total RNA extracted from cultured CGNs relative to a geometric mean of mRNAs encoding the housekeeping enzymes glyceraldehyde phosphate dehydrogenase (GAPDH). Total mRNA was isolated from CGNs cultured for 1–3 days in vitro using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. cDNA was synthesised by reverse transcription using the High Capacity cDNA reverse transcription kit (Applied biosystems) according to the manufacturer’s protocol. Real-time PCR was conducted using the 7500 Real-Time PCR system (Applied Biosystems) with SYBR Green fluorescent probes using the following conditions: 40 cycles of 95 °C for 15 s, 60 °C for 1 min and 72 °C for 30 s. The following primer pairs were used: NgR1 forward, 5′-TCT GCA GTA CCT CTA CCT ACA A-3′; NgR1 reverse, 5′-GTT GCC ATG CAG AAA GAG ATG-3′; NgR2 forward, 5′-CTG TGG CTC TTC TCC AAC AA-3′; NgR2 reverse, 5′-ACC GAG GTC CAG TTC TTC TA-3′; p75NTR forward, 5′-TAC GTT CTC TGA CGT GGT GA-3′; p75NTR reverse, 5′-GTG TTC TGT TTG TTC TGG CA-3′; PirB forward, 5′-CAA ACT GAG GAT GGA GTG GAG-3′; PirB reverse, 5′-GAC ATG ACA GAA GGT GAG ACA T-3′; ITGB1 forward, 5′-CAG GTG TCG TGT TTG TGA ATG-3′; ITGB1 reverse, 5′-GAT CTG ACC ATT TGA CGC TAG A-3′; GAPDH forward, 5′-ACC ACA GTC CAT GCC ATC AC-3′; GAPDH reverse, 5′-CAC CAC CCT GTT GCT GTA GCC-3′. Forward and reverse primers were used at a concentration of 100 nM each. As a standard for assessment of copy number of PCR products, serial concentrations of each PCR fragment were amplified in the same manner. The amount of cDNA was calculated as the copy numbers in each reverse transcription product and normalised to GAPDH values. Eight separate cultures were analysed for each day.
Adult (6–9 months) p75NTR+/+ and p75NTR−/− mice were anaesthetised using CO2 inhalation, the brains were removed and fixed in 4% paraformaldehyde for 24 h. Brains were dehydrated, paraffin embedded and midsagittal sectioned into 5μm consecutive sections. 10 sections from each animal were deparaffinized using xylene and ethanol and stained with hematoxylin and eosin (H&E) using standard methods.
Full-length rat p75NTR was expressed from a pcDNA3 vector backbone (Invitrogen). The p75NFkB and p75RhoGDI/cell death mutant constructs have been described previously35 and correspond to the triple mutant D355A/H359A/E363A and the double mutant D410A/S413A, respectively. The EGFP plasmid was obtained from Clontech.
P7 p75NTR+/+ and p75NTR−/− CGNs were trypsinized and plated at a density of 40,000 cells per coverslip coated with poly-l-lysine (Sigma, Cat: P7280) in a 24-well plate (Starlab) in basal medium Eagle (BME) supplemented with 10% fetal calf serum (Gibco, Cat: 21010-046), 25 mM KCl (Sigma, Cat: P9541), 1 mM glutamine (Gibco, Cat:25030149) and 2 mg/ml gentamicin (Invitrogen, Cat: 15750060). For assessing cleaved caspase 3, neurons were treated for 24 h starting at the 2 day in vitro. The cells were labelled with cleaved caspase 3 (Cell signal, 9761, 1:400), β-III tubulin (R&D systems, MAB1195, 1:1000) and DAPI. For each experiment and treatment, neurons were cultured in duplicates and at least 15 images were taken per coverslip.
For neurite outgrowth the cells were plated in duplicates at a low density of 5000 cells per coverslip. Treatment started 2 h after plating and lasted for 24 h. Neurons were labelled with β-III tubulin (R&D systems, MAB1195, 1:1000) and DAPI after treatment. 10 images per coverslip were taken using a fluorescence microscope and counted to obtain percentage cleaved caspase 3 over DAPI positive cells.
For transfection experiments, CGNs were cultured at density of 40 000 cells per coverslip. Neurons were transfected with either pcDNA3, full-length p75wt, p75NFkB or p75RhoGDI/cell death plasmids using Lipofectamine LTX kit (Invitrogen, Cat: 15338500) 48 h after plating. 250 ng plasmid per well in the 24-well plate was used.
To collect protein for immunoblotting, wild type neurons were cultured at a high density (~200,000 neurons per well) in a 48-well plate. 2 days after plating, neurons were serum, NGF and KCl deprived for 30 min prior to treatment. Cells were then stimulated with either Fc fragment or MAG-Fc for 15 min.
Purified recombinant Fc-fragment (Cat: Ab902285) was purchased from Abcam and MAG-Fc (Cat: 538) was obtained from R&D Systems. ROCK inhibitor (Y-27632, Cat: 72302) was obtained from Stemcell technologies and JNK inhibitor (JNK-IN-8; Cat: 420150) was purchased from Millipore. Caspase inhibitor (Z-DEVD-FMK; Cat 2166) was purchased from Tocris.
Immunoblotting protein samples were prepared for SDS-PAGE in SDS sample buffer (Life Technologies) and boiled at 95 °C for 10 min before electrophoresis on 12% gels. Proteins were transferred to PVDF membranes (Amersham). Membranes were blocked with 5% non-fat milk and incubated with primary antibodies. The following primary antibodies were used at the indicated dilutions: rabbit phospho-c-Jun (Thr91) (Cell signaling, 2303, 1:1000), rabbit anti-c-Jun (Cell signaling, 9165, 1:1000) and rabbit anti-GAPDH (Sigma, G9545, 1:1000). Immunoreactivity was visualised using appropriate HRP-conjugated secondary antibodies. Immunoblots were developed using the ECL Advance Western blotting detection kit (Life Technologies) and exposed to Kodak X-Omat AR films. Image analysis and quantification of band intensities was done with ImageQuant (GE Healthcare).
Data are expressed as mean and standard errors (s.e.m). No statistical methods were used to predetermine sample sizes but our sample sizes are similar to those generally used in the field. Following normality test and homogeneity variance (F-test or Kolmogorov-Smirnov test with Dallal-Wilkinson-Lilliefor p value), group comparison was made using a unpaired student t-test, one-way or two-way ANOVA as appropriate followed by Bonferroni post hoc test for normally distributed data. Mann–Whitney test was done on non-normal distributed data. Differences were considered significant for p < 0.05. The experiments were not randomised. Data from all experiments are included; none were excluded.
Carletti, B. & Rossi, F. Neurogenesis in the cerebellum. Neuroscientist 14, 91–100 (2008).
Trapp, B. D. Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in quaking mouse peripheral nerve. J. Cell Biol. 107, 675–685 (1988).
Heath, J. W., Inuzuka, T., Quarles, R. H. & Trapp, B. D. Distribution of P0 protein and the myelin-associated glycoprotein in peripheral nerves from Trembler mice. J. Neurocytol. 20, 439–449 (1991).
McKerracher, L. et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13, 805–811 (1994).
Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R. & Filbin, M. T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13, 757–767 (1994).
Filbin, M. T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4, 703–713 (2003).
Goh, E. L. K. et al. beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones. Mol. Brain 1, 10 (2008).
Yamashita, T., Higuchi, H. & Tohyama, M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157, 565–570 (2002).
Yamashita, T. & Tohyama, M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 6, 461–467 (2003).
Mehta, N. R., Lopez, P. H. H., Vyas, A. A. & Schnaar, R. L. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J. Biol. Chem. 282, 27875–27886 (2007).
Geoffroy, C. G. & Zheng, B. Myelin-associated inhibitors in axonal growth after CNS injury. Curr. Opin. Neurobiol. 27, 31–38 (2014).
Liu, B. P., Fournier, A., GrandPré, T. & Strittmatter, S. M. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297, 1190–1193 (2002).
Wong, S. T. et al. A p75NTR and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5, 1302–1308 (2002).
Vinson, M. et al. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J. Biol. Chem. 276, 20280–20285 (2001).
Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R. & He, Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420, 74–78 (2002).
Venkatesh, K. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci. 25, 808–822 (2005).
Carter, B. D. et al. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 272, 542–p545 (1996).
Khursigara, G. et al. A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J. Neurosci. 21, 5854–5863 (2001).
McCarthy, J. V., Ni, J. & Dixit, V. M. RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273, 16968–16975 (1998).
Vicario, A., Kisiswa, L., Tann, J. Y., Kelly, C. E. & Ibanez, C. F. Neuron-type-specific signaling by the p75NTR death receptor is regulated by differential proteolytic cleavage. J. Cell Sci. 128, 1507–1517 (2015).
Friedman, W. J. Neurotrophins induce death of hippocampal neurons via the p75 receptor. J. Neurosci. 20, 6340–6346 (2000).
Wicovsky, A. et al. Sustained JNK activation in response to tumor necrosis factor is mediated by caspases in a cell type-specific manner. J. Biol. Chem. 282, 2174–2183 (2007).
Niederöst, B., Oertle, T., Fritsche, J., McKinney, R. A. & Bandtlow, C. E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 22, 10368–10376 (2002).
Fournier, A. E., Takizawa, B. T. & Strittmatter, S. M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23, 1416–1423 (2003).
Domeniconi, M. et al. MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 46, 849–855 (2005).
Chaudhry, N. et al. Myelin-associated glycoprotein inhibits schwann cell migration and induces their death. J. Neurosci. 37, 5885–5899 (2017).
Kisiswa, L., Fernández-Suárez, D., Sergaki, M. C. & Ibáñez, C. F. RIP2 gates TRAF6 interaction with death receptor p75NTRto regulate cerebellar granule neuron survival. Cell Rep. 24, 1013–1024 (2018).
Shen, Y. J., DeBellard, M. E., Salzer, J. L., Roder, J. & Filbin, M. T. Myelin-associated glycoprotein in myelin and expressed by Schwann cells inhibits axonal regeneration and branching. Mol. Cell. Neurosci. 12, 79–91 (1998).
Huang, J. Y. et al. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells. Brain Res. 1437, 1–15 (2012).
Dubois-Dalcq, M., Behar, T., Hudson, L. & Lazzarini, R. A. Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J. Cell Biol. 102, 384–392 (1986).
Fujita, Y., Takashima, R., Endo, S., Takai, T. & Yamashita, T. The p75 receptor mediates axon growth inhibition through an association with PIR-B. Cell Death Dis. 2, 198 (2011).
Ventresca, E. M. et al. Association of p75NTR and α9β1 integrin modulates NGF-dependent cellular responses. Cell. Signal. 27, 1225–1236 (2015).
Atwal, J. K. et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322, 967–970 (2008).
Mehta, N. R., Nguyen, T., Bullen, J. W., Griffin, J. W. & Schnaar, R. L. Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism. ACS Chem. Neurosci. 1, 215–222 (2010).
Charalampopoulos, I. et al. Genetic dissection of neurotrophin signaling through the p75 neurotrophin receptor. Cell Rep. 2, 1563–1570 (2012).
Lin, Z. et al. Structural basis of death domain signaling in the p75 neurotrophin receptor. Elife 4, 11692 (2015).
Reddy, C. E. et al. Multisite phosphorylation of c-Jun at threonine 91/93/95 triggers the onset of c-Jun pro-apoptotic activity in cerebellar granule neurons. Cell Death Dis. 4, 852 (2013).
Venkatesh, K., Chivatakarn, O., Sheu, S. S. & Giger, R. J. Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type-specific mechanisms for neurite outgrowth inhibition. J. Cell Biol. 177, 393–399 (2007).
Lee, J. K. et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 10-66, 663–670 (2010).
Lopez, P. H. H. et al. Myelin-associated glycoprotein protects neurons from excitotoxicity. J. Neurochem. 116, 900–908 (2011).
Mimura, F. et al. Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism. J. Biol. Chem. 281, 15970–15979 (2006).
Petratos, S. et al. Expression of the low-affinity neurotrophin receptor, p75NTR, is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination. Glia 48, 64–75 (2004).
Goldowitz, D., Hamre, K. M., Przyborski, S. A. & Ackerman, S. L. Granule cells and cerebellar boundaries: analysis of Unc5h3 mutant chimeras. J. Neurosci. 20, 4129–4137 (2000).
Zheng, B. et al. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. USA 25-102, 1205–1210 (2005).
Palandri, A. et al. Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75 NTR receptor-mediated activation of RhoA signaling pathways. Cell Death Dis. 6, 1876 (2015).
Lee, K. F. et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737–749 (1992).
We thank Ket Yin Goh and Eunice Sim Weiling for technical support. This research was supported by grants to LK from Karolinska Institute Research Foundation and Magnus Bergwall Foundation.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by A. Verkhratsky
About this article
Cite this article
Fernández-Suárez, D., Krapacher, F.A., Andersson, A. et al. MAG induces apoptosis in cerebellar granule neurons through p75NTR demarcating granule layer/white matter boundary. Cell Death Dis 10, 732 (2019). https://doi.org/10.1038/s41419-019-1970-x
A multi-omic study for uncovering molecular mechanisms associated with hyperammonemia-induced cerebellar function impairment in rats
Cell Biology and Toxicology (2021)
Developmental Maturation of the Cerebellar White Matter—an Instructive Environment for Cerebellar Inhibitory Interneurons
The Cerebellum (2020)